Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RDHL

RedHill Biopharma

$10.29

0.0199 (0.19%)

07:55
04/27/17
04/27
07:55
04/27/17
07:55
Conference/Events
RedHill Biopharma to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

RDHL

RedHill Biopharma

$10.29

0.0199 (0.19%)

04:55
04/27/17
04/27
04:55
04/27/17
04:55
Conference/Events
RedHill Biopharma to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 03

    May

Monday
RDHL

RedHill Biopharma

$10.38

0.41 (4.11%)

07:01
04/24/17
04/24
07:01
04/24/17
07:01
Hot Stocks
RedHill Biopharma announces enrollment of last patient in Bekinda Phase II study »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Over a week ago
RDHL

RedHill Biopharma

$9.82

-0.03 (-0.30%)

07:24
04/20/17
04/20
07:24
04/20/17
07:24
Hot Stocks
RedHill Biopharma's Yeliva Phase I results published in peer-reviewed journal »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RDHL

RedHill Biopharma

$9.88

0.02 (0.20%)

09:13
04/18/17
04/18
09:13
04/18/17
09:13
Conference/Events
RedHill Biopharma to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RDHL

RedHill Biopharma

$9.88

0.02 (0.20%)

08:14
04/18/17
04/18
08:14
04/18/17
08:14
Hot Stocks
RedHill Biopharma receives Notices of Allowance for 2 new patents for Bekinda »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RDHL

RedHill Biopharma

$10.12

0.12 (1.20%)

06:03
04/13/17
04/13
06:03
04/13/17
06:03
Hot Stocks
RedHill Biopharma, IntelGenx announces marketing approval of RIZAPORT »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RDHL

RedHill Biopharma

, LPTX

Leap Therapeutics

$8.19

0.13 (1.61%)

07:47
04/07/17
04/07
07:47
04/07/17
07:47
Conference/Events
BioCentury to hold a conference »

24th Annual Future…

RDHL

RedHill Biopharma

LPTX

Leap Therapeutics

$8.19

0.13 (1.61%)

CBAY

CymaBay

$4.17

0.28 (7.20%)

FBIO

Fortress Biotech

$3.37

-0.06 (-1.75%)

DRNA

Dicerna

$3.21

0.11 (3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Apr

  • 27

    Apr

  • 06

    Jun

PRTK

Paratek Pharmaceuticals

$18.60

-0.65 (-3.38%)

, GALE

Galena

$0.59

-0.019 (-3.11%)

09:18
04/04/17
04/04
09:18
04/04/17
09:18
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Paratek…

PRTK

Paratek Pharmaceuticals

$18.60

-0.65 (-3.38%)

GALE

Galena

$0.59

-0.019 (-3.11%)

CTRV

ContraVir Pharmaceuticals

$1.78

0.01 (0.56%)

RDHL

RedHill Biopharma

$9.51

-0.08 (-0.83%)

TEVA

Teva

URBN

Urban Outfitters

$23.20

-0.56 (-2.36%)

AYI

Acuity Brands

BAC

Bank of America

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 18

    Apr

  • 27

    Apr

  • 04

    May

  • 09

    May

  • 06

    Jun

  • 30

    Aug

RDHL

RedHill Biopharma

$9.51

-0.08 (-0.83%)

06:06
04/04/17
04/04
06:06
04/04/17
06:06
Hot Stocks
RedHill Biopharma receives FDA Orphan Drug designation for YELIVA »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.